Suppr超能文献

κ激动剂PD 129290及其R,R(+)-对映体PD 129289的电生理和抗心律失常作用

Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.

作者信息

Pugsley M K, Saint D A, Penz M P, Walker M J

机构信息

Department of Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Br J Pharmacol. 1993 Dec;110(4):1579-85. doi: 10.1111/j.1476-5381.1993.tb14004.x.

Abstract
  1. The S,S (-)-enantiomer PD 129290, a kappa agonist, and its corresponding inactive R,R (+)-enantiomer (PD 129289) were studied in rat isolated hearts and in intact rats for cardiovascular and antiarrhythmic actions. The electrophysiological actions of PD 129290 were also studied in rat isolated cardiac myocytes using voltage clamp. 2. Ventricular pressure, heart rate and ECG were studied in isolated hearts while blood pressure, heart rate and ECG were studied in pentobarbitone-anaesthetized rats. In the latter, responses to electrical stimulation and coronary occlusion were also investigated. 3. In isolated hearts both enantiomers, over the concentration range 2-16 microM, dose-dependently reduced systolic ventricular pressure and heart rate while prolonging the P-R and QRS intervals of the ECG. 4. At doses of 1-32 mumol kg-1 both enantiomers reduced blood pressure and heart rate in anaesthetized rats. In addition, both enantiomers increased the size of the RSh and increased P-R, QRS, and Q-T intervals of the ECG. The thresholds for premature beats and ventricular fibrillation were dose-dependently increased by PD 129289. At lower doses PD 129290 decreased thresholds. These decreases were blocked by naloxone to reveal underlying increases similar to those seen with PD 129289. Both enantiomers increased refractory periods. 5. Naloxone (8 mumol kg-1) did not alter any of the actions of PD 129290, except to abolish the initial decreases in thresholds in intact rats seen with lower doses of PD 129290. 6. Both enantiomers (2 and 8 mumol kg-1) equally reduced arrhythmias in anaesthetized rats subject to occlusion of a coronary artery. 7. In rat isolated cardiac myocytes 20 microM PD 129290, in the presence and absence of naloxone decreased the amplitude of the transient sodium current by about 50% without affecting the voltage dependence of activation or inactivation of this current.8. The antiarrhythmic actions of both enantiomers appear to primarily result from their Class I(sodium channel blockade) properties which are independent of kappa agonism.
摘要
  1. 对κ激动剂S,S (-)-对映体PD 129290及其相应的无活性R,R (+)-对映体(PD 129289)在大鼠离体心脏和完整大鼠中进行了心血管和抗心律失常作用的研究。还使用电压钳在大鼠离体心肌细胞中研究了PD 129290的电生理作用。2. 在离体心脏中研究心室压力、心率和心电图,而在戊巴比妥麻醉的大鼠中研究血压、心率和心电图。在后者中,还研究了对电刺激和冠状动脉闭塞的反应。3. 在离体心脏中,两种对映体在2 - 16微摩尔的浓度范围内,剂量依赖性地降低心室收缩压和心率,同时延长心电图的P-R和QRS间期。4. 在1 - 32微摩尔/千克的剂量下,两种对映体均降低麻醉大鼠的血压和心率。此外,两种对映体均增加RSh的幅度,并增加心电图的P-R、QRS和Q-T间期。PD 129289剂量依赖性地增加早搏和心室颤动的阈值。在较低剂量下,PD 129290降低阈值。这些降低被纳洛酮阻断,以揭示与PD 129289所见相似的潜在增加。两种对映体均增加不应期。5. 纳洛酮(8微摩尔/千克)未改变PD 129290的任何作用,除了消除在完整大鼠中较低剂量的PD 129290所见的初始阈值降低。6. 两种对映体(2和8微摩尔/千克)在冠状动脉闭塞的麻醉大鼠中同等程度地减少心律失常。7. 在大鼠离体心肌细胞中,20微摩尔的PD 129290,无论有无纳洛酮,均使瞬时钠电流幅度降低约50%,而不影响该电流激活或失活的电压依赖性。8. 两种对映体的抗心律失常作用似乎主要源于其I类(钠通道阻滞)特性,这与κ激动作用无关。

相似文献

4
An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.κ-阿片受体激动剂PD117,302的心脏作用研究。
Eur J Pharmacol. 2015 Aug 15;761:330-40. doi: 10.1016/j.ejphar.2015.06.018. Epub 2015 Jun 15.
7

引用本文的文献

10
Endogenous opiates: 1993.内源性阿片类物质:1993年。
Peptides. 1994;15(8):1513-56. doi: 10.1016/0196-9781(94)90131-7.

本文引用的文献

2
Pharmacology of opioids.阿片类药物的药理学
Pharmacol Rev. 1983 Dec;35(4):283-323.
3
An improved perfusion apparatus for small animal hearts.一种改进的用于小动物心脏的灌注装置。
J Pharmacol Methods. 1986 Feb;15(1):87-94. doi: 10.1016/0160-5402(86)90008-2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验